Displaying 1 - 1 of 1

New license could improve tuberculosis treatment for people living with HIV

The World Council of Churches - Ecumenical Advocacy Alliance applauds the first licensing agreement related to tuberculosis, announced on 25 January by the Medicines Patent Pool and Johns Hopkins University. The agreement will facilitate the clinical development of sutezolid, a tuberculosis drug candidate. The antibiotic sutezolid, in combination with other drugs, could be used to more effectively treat drug-sensitive and drug-resistant tuberculosis.